Maternal exposure to carbamazepine at environmental concentrations can cross intestinal and placental barriers
Open Access
- 1 May 2016
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 474 (2) , 291-295
Abstract
No abstract availableKeywords
Funding Information
- Institutional Development Award (IDeA)
- National Institute of General Medical Sciences of the National Institutes of Health (#P20GM103408)
This publication has 27 references indexed in Scilit:
- The use of psychotropic medication during pregnancy: how about the newborn?Neuropsychiatric Disease and Treatment, 2013
- Psychoactive Pharmaceuticals Induce Fish Gene Expression Profiles Associated with Human Idiopathic AutismPLOS ONE, 2012
- Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systemsComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2012
- Genetics of autism spectrum disordersTrends in Cognitive Sciences, 2011
- A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autismMolecular Autism, 2011
- Pericytes are required for blood–brain barrier integrity during embryogenesisNature, 2010
- Teratogenic effects of carbamazepine on embryonic eye development in pregnant miceCutaneous and Ocular Toxicology, 2009
- Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic DrugsNew England Journal of Medicine, 2009
- Autism: Many Genes, Common Pathways?Cell, 2008
- The blood–brain barrier: an overviewNeurobiology of Disease, 2004